Skip to content
Search

Latest Stories

Pharmacist Support launches mental health programme for pharmacy students

Pharmacist Support, the profession’s independent charity, has launched a campaign to help students focus on their mental wellbeing, anxiety, and make them feel mentally prepared for their exams.

Backing the programme, the Pharmacists' Defence Association has been encouraging pharmacy students to sign up for the Student charity's ACTNow campaign, which has started running from Wednesday.


ACTNow is Pharmacist Support’s annual wellbeing campaign, which at key points throughout the year, focuses on the specific needs and issues for students, trainees and pharmacists.

The current campaign focusses on putting everyday wellbeing into practice and supporting students with university life, such as overcoming social anxiety, public speaking, and bullying. It encourages pharmacy students to allow time for wellbeing, consider the needs of others, and take action.

Pharmacy students will need to sign up to the campaign to make sure they receive all the free, dedicated wellbeing resources and event invitations.

Following the successful segmentation of its ACTNow campaign last year, targeting the wellbeing needs of each grouping in their pharmacy family (students, trainees and pharmacists), Pharmacist Support will again run three targeted wellbeing campaigns in 2022.

The first will focus on the issues experienced by pharmacy students, and centres around exam anxiety, social anxiety and bullying. This campaign which started on Wednesday March 30 will run for a week until April 6.

The second will be the charity’s Trainee ACTNow campaign that will focus on getting mentally prepared for the assessment and the transition to responsible pharmacist. This will run from Wednesday 25th May – 1st June.

The final instalment will be a pharmacist focused campaign that will kick off once again on World Pharmacists Day (September 25) and run for four weeks, ending on October 22.

“Our 2022 ACTNow campaigns will build on the success and momentum of the last two years,” commented Pharmacist Support chief executive Danielle Hunt.

“Whilst the campaigns main aim is to continue to raise the important issue of wellbeing and Pharmacist Support generally, this year it will broaden its focus on wellbeing in the workplace.

“In order to tackle some of the issues highlighted through our research around workplace culture and stigma, we feel it is important to look beyond what individuals can do, and towards what we can all do to create positive environments to allow people to thrive. In 2021 many across the sector took the first step and signed up to the RPS’s Wellbeing and Inclusion Pledge. Through this campaign, we want to further support orgnaisations to deliver on this commitment and embed wellbeing practices into the workplace and place of study by providing practical support.

“Our aspiration is to create a tidal wave of change to reverse the trends of high levels of burnout within the profession. We believe this will only be realised through collaborative working and commitment. We therefore would like to work collaboratively with as many organisations – universities, employers, managers and membership bodies - across the sector as possible.”

More For You

Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less